Vaccinations for the pediatric traveler

Sheila M Mackell1

  • 1Mountain View Pediatrics, Flagstaff, Arizona 86001, USA.

Insights

Protecting traveling children requires updated routine immunizations and specific travel vaccines, considering pediatric immune responses and age-related vaccine schedules. This review details US recommendations for pediatric travel vaccinations.

Area of Science:

  • Pediatric infectious diseases
  • Travel medicine
  • Immunology

Background:

  • Pediatric travel medicine has grown complex due to evolving vaccine recommendations.
  • Children's unique immune responses and age-specific vaccination needs are critical considerations.
  • Travel health for children necessitates both updated routine immunizations and specific travel vaccines.

Purpose of the Study:

  • To review vaccine considerations for children traveling internationally.
  • To outline current US recommendations for pediatric travel vaccinations.
  • To address age-specific vaccine needs and potential acceleration of routine series.

Main Methods:

  • Literature review of vaccine developments and pediatric travel health guidelines.
  • Analysis of current US immunization schedules and travel vaccine indications.
  • Examination of age-related immune responses and vaccine safety profiles.

Main Results:

  • Routine childhood immunizations may require acceleration for infants traveling early.
  • Specific travel vaccines (e.g., Hepatitis A, Japanese encephalitis) have pediatric indications, side effects, and uses.
  • Consideration of itinerary-specific vaccines is crucial for protecting traveling children.

Conclusions:

  • Optimizing travel health for children involves a comprehensive approach to immunization.
  • Adherence to updated US recommendations ensures appropriate vaccine use in pediatric travelers.
  • Understanding pediatric immune responses informs vaccine selection and scheduling for international travel.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...